MSA
GILD icon

MUFG Securities Americas’s Gilead Sciences GILD Stock Holding History

MUFG Securities Americas’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.78M Buy
34,330
+906
+3% +$127K 0.31% 58
2025
Q4 		$4.1M Sell
33,424
-36
-0.1% -$4.38K 0.26% 76
2025
Q3 		$3.71M Buy
33,460
+5,891
+21% +$670K 0.24% 82
2025
Q2 		$3.06M Buy
27,569
+5,509
+25% +$586K 0.26% 71
2025
Q1 		$2.47M Buy
22,060
+3,663
+20% +$378K 0.29% 68
2024
Q4 		$1.7M Buy
+18,397
New +$1.66M 0.22% 89

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

MUFG Securities Americas's GILD Position: Q1 2026 in Review

MUFG Securities Americas increased its Gilead Sciences (GILD) stake by 2.7% in Q1 2026, buying an estimated $127K and bringing the position to 34,330 shares worth $4.78M. The position accounts for 0.31% of the portfolio, ranked #58.

MUFG Securities Americas first reported a position in GILD in Q4 2024 and has held it in 6 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • MUFG Securities Americas held 34,330 shares of Gilead Sciences worth $4.78M as of Q1 2026.
  • MUFG Securities Americas bought 906 Gilead Sciences shares in Q1 2026, an estimated $127K.
  • Gilead Sciences made up 0.31% of MUFG Securities Americas's portfolio in Q1 2026, its #58 holding.
  • MUFG Securities Americas first reported a position in Gilead Sciences in Q4 2024 and has held it in 6 quarters since.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on MUFG Securities Americas's 13F filing for Q1 2026, filed 11 May 2026.